Ubrogepant Impurity 15 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), quality control (QC) applications for Abbreviated New Drug Applications (ANDA), as well as during the commercial manufacturing of Ubrogepant